Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization.
Humans
Diabetic Retinopathy
/ diagnostic imaging
Macula Lutea
/ diagnostic imaging
Neovascularization, Pathologic
/ pathology
Angiography
Fundus Oculi
Tomography, Optical Coherence
/ methods
Intravitreal Injections
Fluorescein Angiography
/ methods
Angiogenesis Inhibitors
/ therapeutic use
Retrospective Studies
Diabetes Mellitus
/ pathology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
28 09 2023
28 09 2023
Historique:
received:
15
03
2023
accepted:
26
09
2023
medline:
2
10
2023
pubmed:
29
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
The purpose of this study was to investigate the effect of diabetic retinopathy (DR) on longitudinal morphological changes in AMD-associated type 1 macular neovascularization using optical coherence tomography angiography (OCTA). We enrolled fifty treatment-naïve eyes with a diagnosis of exudative AMD and type 1 MNV. Twenty of 50 eyes were affected by mild DR. En face OCT angiography were examined for the MNV lesion area (mm
Identifiants
pubmed: 37770616
doi: 10.1038/s41598-023-43635-4
pii: 10.1038/s41598-023-43635-4
pmc: PMC10539526
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
16337Informations de copyright
© 2023. Springer Nature Limited.
Références
Retina. 2017 Feb;37(2):247-256
pubmed: 27628926
Arch Ophthalmol. 2011 Feb;129(2):196-9
pubmed: 21320966
Ophthalmologe. 2015 Mar;112(3):246-54
pubmed: 25668709
Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2087-2093
pubmed: 35122134
Lancet. 2012 May 5;379(9827):1728-38
pubmed: 22559899
Ophthalmology. 2005 Apr;112(4):533-9
pubmed: 15808240
Transl Vis Sci Technol. 2019 Nov 12;8(6):5
pubmed: 31737429
Ophthalmology. 1985 Apr;92(4):512-22
pubmed: 2582331
Prog Retin Eye Res. 2018 May;64:1-55
pubmed: 29229445
Eye (Lond). 2017 Aug;31(8):1176-1183
pubmed: 28387762
Retina. 2020 Mar;40(3):428-445
pubmed: 31415449
N Engl J Med. 2006 Oct 5;355(14):1419-31
pubmed: 17021318
Ophthalmology. 2020 Apr;127(4S):S99-S119
pubmed: 32200833
Ophthalmic Epidemiol. 1999 Jun;6(2):125-43
pubmed: 10420212
Transl Vis Sci Technol. 2022 Sep 1;11(9):18
pubmed: 36135978
Invest Ophthalmol Vis Sci. 2023 Apr 3;64(4):21
pubmed: 37074695
Retina. 2020 Jun;40(6):1062-1069
pubmed: 30986798
Ophthalmology. 2014 Jan;121(1):193-201
pubmed: 24084500
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):11
pubmed: 32902576
Retina. 2020 Nov;40(11):2106-2112
pubmed: 32658166
Ophthalmic Res. 2015;54(2):57-63
pubmed: 26201877
Retina. 2015 Nov;35(11):2252-9
pubmed: 26457400
Ophthalmology. 2008 Dec;115(12):2206-14
pubmed: 18930551
Biomed Opt Express. 2012 Jun 1;3(6):1182-99
pubmed: 22741067
Lancet. 2013 Oct 12;382(9900):1258-67
pubmed: 23870813
Ophthalmology. 2015 Jun;122(6):1228-38
pubmed: 25795476
Ophthalmology. 2004 Jul;111(7):1280-7
pubmed: 15234127
Indian J Ophthalmol. 2021 Nov;69(11):3184-3188
pubmed: 34708768
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
J Clin Med. 2020 Apr 24;9(4):
pubmed: 32344742
Eur J Ophthalmol. 2014 May-Jun;24(3):396-401
pubmed: 24242222
PLoS One. 2014 Sep 19;9(9):e108196
pubmed: 25238063